Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis.

Stopfer, P

Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis. [electronic resource] - Clinical and experimental immunology Apr 2004 - 21-9 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0009-9104

10.1111/j.1365-2249.2004.02402.x doi


Animals
Cell Adhesion Molecules
Chronic Disease
Colitis, Ulcerative--chemically induced
Cytokines--metabolism
Dextran Sulfate
Disease Models, Animal
Down-Regulation--drug effects
Female
Immunoglobulins--metabolism
Intestinal Mucosa--blood supply
Leukocytes--physiology
Ligands
Lymphotoxin beta Receptor
Mice
Mice, Inbred BALB C
Microcirculation
Mucoproteins--metabolism
Receptors, Tumor Necrosis Factor--antagonists & inhibitors